EDGAR Filing Documents for 0001144204-18-000347

Form 8-K - Current report:

SEC Accession No. 0001144204-18-000347

Filing Date

2018-01-03

Accepted

2018-01-03 09:05:35

Documents

Period of Report

2017-12-27

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	tv482498_8k.htm	8-K	54182
2	EXHIBIT 3.1	tv482498_ex3-1.htm	EX-3.1	93374
3	EXHIBIT 4.1	tv482498_ex4-1.htm	EX-4.1	87895
4	EXHIBIT 10.1	tv482498_ex10-1.htm	EX-10.1	189377
5	EXHIBIT 10.2	tv482498_ex10-2.htm	EX-10.2	155087
6	EXHIBIT 99.1	tv482498_ex99-1.htm	EX-99.1	14767
7	GRAPHIC	image_001.jpg	GRAPHIC	2218
	Complete submission text file	0001144204-18-000347.txt		599450

Mailing Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746

Business Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746 (774) 233-7300

Biostage, Inc. (Filer) CIK: 0001563665 (see all company filings)